TLSI TriSalus Life Sciences, Inc.: institutional ownership and insider trading
84 funds reported holding $111M of TriSalus Life Sciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $2.84M, with 10 new positions and 16 funds selling out; over the last 12 months insiders bought $3.61M and sold $140K on the open market.
Largest institutional holders of TLSI
- First Light Asset Management, LLC — $29.8M
- BlackRock, Inc. (BLK) — $12.1M
- VANGUARD GROUP INC — $10.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $7.87M
- Cerity Partners LLC — $7.30M
- GEODE CAPITAL MANAGEMENT, LLC — $5.42M
- Nantahala Capital Management, LLC — $4.55M
- GILDER GAGNON HOWE & CO LLC — $3.87M
- STATE STREET CORP (STT, STT-PG) — $2.78M
- WHITE PINE CAPITAL LLC — $2.49M
Recent TLSI insider trades
- Oct 5, 2026: Stevens Jennifer sold 316 shares ($1.39K)
- Oct 5, 2026: Marshak Richard sold 325 shares ($1.43K)
- Oct 5, 2026: Cox Bryan F. sold 296 shares ($1.30K)
- May 15, 2026: Marshak Richard sold 543 shares ($1.45K)
5%+ owners
- First Light Asset Management, LLC: 10.7% (Schedule 13G/A, filed Jul 7, 2026)
- Utmost Group PLC: 5.7% (Schedule 13G, filed May 12, 2026)
- James J. Pallotta: 5.2% (Schedule 13G/A, filed May 20, 2026)